Cancer in the Commonwealth: a Lancet Oncology Commission

By afschroeder • November 5, 2026

Atun R, Sirohi B, Jaffray D, Aggarwal A, Bustamam RSA, Allemani C, Dsane LB, Borin G, Canfell K, Chaudry MA, Dare AJ, Du A, Essue BM, Figi JT, Ghose A, Giuliani M, Gurney J, Head MG, Ilbawi A, Irish JC, Jackson CGCA, Jenei K, Johnson SE, Knaul FM, Lodge M, Mutebi M, Ntizimira C, Ostwald DA, Pramesh CS, Reddy CL, Renner LA, Rodin D, Schmitt M, Shinkafi-Bagudu Z, Soerjomataram I, Spence D, Stanway S, Stein DT, Sukumar S, Tittenbrun Z, Warwick L, Ward ZJ, Woo YL, Yap ML, Gospodarowicz M; Cancer in the Commonwealth Commission Working Groups. Cancer in the Commonwealth: a Lancet Oncology Commission. Lancet Oncol. 2026 Nov 4:S1470-2045(26)00396-7. doi: 10.1016/S1470-2045(26)00396-7. Epub ahead of print. PMID: 42982064.

Tags: General Internal Medicine, Publications

Collaborative Solutions to Identify Scheduling Barriers for Timely Post-Hospital Discharge Primary Care Follow-Up: A Quality Improvement Initiative

Le B, Simon W, Zhang J, Robertson J, Dowling E. Collaborative Solutions to Identify Scheduling Barriers for Timely Post-Hospital Discharge Primary Care Follow-Up: A Quality[...]

AI Timeouts: A Structured Approach to Deliberate AI Use in Clinician Education

Tran G, Lee E, Patel S. AI Timeouts: A Structured Approach to Deliberate AI Use in Clinician Education. J Brown Hosp Med. 2026 Oct 1;5(4):170189.[...]

Exanthematous drug eruption with reactive T-cell atypia in a patient with accelerated chronic lymphocytic leukemia

Dong S, Jaeger ZJ, Hinds B, Weiss DI, Schneider J, Liou YL. Exanthematous drug eruption with reactive T-cell atypia in a patient with accelerated chronic[...]